Downregulation of type I collagen expression in the Achilles tendon by dexamethasone: a controlled laboratory study.
Ontology highlight
ABSTRACT: BACKGROUND:Spontaneous Achilles tendon rupture associated with long-term dexamethasone (Dex) use has been reported. However, few studies have investigated the potential mechanism. The aim of this study was to evaluate the effects of oral Dex on type I collagen in humans and rats and its association with tendon rupture. METHODS:First, six Achilles tendons from patients who received long-term Dex treatment, and another six normal tendons were harvested for histological evaluation. Secondly, 8-week-old rats (n?=?72) were randomly assigned to a Dex group or a control group. Type I collagen was studied at the mechanical, histological, and molecular levels after 3 and 5?weeks. Tenocytes isolated from normal human and rat tendon were used to investigate the effect of Dex on cellular scale. RESULTS:Histological analysis of human and rat tendon tissue revealed an irregular, disordered arrangement of type I collagen in the Dex group compared with the control group. In addition, In the Dex+ group, type I collagen expression decreased in comparison with the Dex- group in both human and rat tenocytes. The mechanical strength of tendons was significantly reduced in the Dex group (68.87?±?11.07?N) in comparison with the control group (81.46?±?7.62?N, P?=?0.013) after 5?weeks. Tendons in the Dex group were shorter with smaller cross-sectional areas (10.71?±?0.34?mm2, 1.44?±?0.22?mm2, respectively) after 5?weeks than those in the control group (11.13?±?0.50?mm2, P?=?0.050, 2.74?±?0.34?mm2, P?
SUBMITTER: Ge Z
PROVIDER: S-EPMC7038574 | biostudies-literature | 2020 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA